The Basel-based pharmaceutical company Myovant Sciences has published positive study results for its therapy relugolix, which has now been shown to be effective and safe…
The BaseLaunch Healthcare Accelerator program from BaselArea.swiss started on September 14. Over 100 applications were received from more than 30 countries, and the selection committee…
BaseLaunch Accelerator gains another healthcare partner Pharma and diagnostics company Roche has joined Johnson & Johnson Innovation, Novartis Venture Fund and Pfizer to become the…
Aurealis Pharma AG has closed a 5.6 million Swiss franc financing round. Headquartered in Basel and Finland, the biotechnology company develops medications for cancer and…